CGC-738

N/A

Report date: 2025/02/20 20:00:06

Base Information

Drug NameCGC-738
Drug Alias NameCGC738CGC-738
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy
Mechanisms of ActionNatural killer cell replacementsCD70 antigen modulators
TargetsCD70 antigen
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesSuzhou Cure Genetics Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Cure Genetics Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A